AEM vs IOSP

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

IOSP presents as a financially stable, defensive value play with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet. While the stock trades almost exactly at its Graham Number ($74.99), suggesting fair defensive value, it trades at a significant premium to its growth-based intrinsic value ($32.69). The company demonstrates a strong track record of earnings beats, but this is offset by negative revenue growth and bearish insider sentiment. Overall, the lack of growth catalysts and poor long-term price performance temper the appeal of its strong solvency.